Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The HOT Study: Hormone Replacement Therapy Opposed by Low Dose Tamoxifen. A Phase III Trial of Breast Cancer Prevention With Low Dose Tamoxifen in HRT Users.

NCT01579734 is registered in ClinicalTrials.gov with European Institute of Oncology as lead sponsor.

NCT NCT01579734
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01579734 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The HOT Study: Hormone Replacement Therapy Opposed by Low Dose Tamoxifen. A Phase III Trial of Breast Cancer Prevention With Low Dose Tamoxifen in HRT Users.
Lead sponsor
European Institute of Oncology
Phase
Phase 3
Overall status
Unknown status
Start date
March 31, 2002
Completion date
December 31, 2023
Enrollment
1,884 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer